ME02208B - Separacija enantiomera triazin derivata koristeći tartaratnu kiselinu - Google Patents

Separacija enantiomera triazin derivata koristeći tartaratnu kiselinu

Info

Publication number
ME02208B
ME02208B MEP-2015-154A MEP15415A ME02208B ME 02208 B ME02208 B ME 02208B ME P15415 A MEP15415 A ME P15415A ME 02208 B ME02208 B ME 02208B
Authority
ME
Montenegro
Prior art keywords
separation
tartaric acid
triazine derivatives
enantiomers
derivatives enantiomers
Prior art date
Application number
MEP-2015-154A
Other languages
English (en)
Inventor
Matthias Helmreich
Daniel Cravo
Original Assignee
Poxel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poxel filed Critical Poxel
Publication of ME02208B publication Critical patent/ME02208B/me

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/10Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MEP-2015-154A 2010-12-01 2011-11-30 Separacija enantiomera triazin derivata koristeći tartaratnu kiselinu ME02208B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10306327 2010-12-01
PCT/EP2011/071347 WO2012072663A1 (en) 2010-12-01 2011-11-30 Separation of triazine derivatives enantiomers using tartaric acid
EP11788512.9A EP2646422B1 (en) 2010-12-01 2011-11-30 Separation of triazine derivatives enantiomers using tartaric acid

Publications (1)

Publication Number Publication Date
ME02208B true ME02208B (me) 2016-02-20

Family

ID=45047827

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2015-154A ME02208B (me) 2010-12-01 2011-11-30 Separacija enantiomera triazin derivata koristeći tartaratnu kiselinu

Country Status (24)

Country Link
US (1) US8742103B2 (me)
EP (1) EP2646422B1 (me)
JP (1) JP5758010B2 (me)
KR (1) KR101530924B1 (me)
CN (1) CN103228635B (me)
AU (1) AU2011334992B2 (me)
BR (1) BR112013010115B1 (me)
CA (1) CA2816357C (me)
CY (1) CY1117407T1 (me)
DK (1) DK2646422T3 (me)
EA (1) EA022300B1 (me)
ES (1) ES2548038T3 (me)
HR (1) HRP20151022T1 (me)
HU (1) HUE026090T2 (me)
IL (1) IL226053A (me)
ME (1) ME02208B (me)
MX (1) MX345822B (me)
PL (1) PL2646422T3 (me)
PT (1) PT2646422E (me)
RS (1) RS54397B1 (me)
SI (1) SI2646422T1 (me)
SM (1) SMT201500230B (me)
TW (1) TWI428311B (me)
WO (1) WO2012072663A1 (me)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020003243A (es) 2017-10-02 2020-09-18 Poxel Métodos para tratar la insuficiencia cardíaca con fracción de eyección preservada.
WO2019236844A1 (en) 2018-06-06 2019-12-12 Metavant Sciences Gmbh Methods of treating subjects having diabetes with chronic kidney disease
CN112218623A (zh) 2018-06-14 2021-01-12 博希尔公司 用于治疗糖尿病的包含三嗪衍生物的薄膜包衣片剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804113B1 (fr) * 2000-01-26 2004-06-18 Lipha Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
FR2853650B1 (fr) 2003-04-10 2006-07-07 Merck Sante Sas Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance
US7458318B2 (en) 2006-02-01 2008-12-02 Speedline Technologies, Inc. Off-axis illumination assembly and method
DE102008007314A1 (de) 2008-02-02 2009-08-06 Merck Patent Gmbh Verfahren zur Herstellung von 3,6-Dihydro-1,3,5-triazinderivaten
RS54736B1 (sr) 2008-05-23 2016-10-31 Poxel Sas Postupak za sintezu derivata 3,6-dihidro-1,3,5-triazina

Also Published As

Publication number Publication date
KR20130093160A (ko) 2013-08-21
AU2011334992A1 (en) 2013-05-30
HRP20151022T1 (hr) 2015-12-18
TW201228999A (en) 2012-07-16
AU2011334992B2 (en) 2016-03-24
IL226053A0 (en) 2013-06-27
US20130261300A1 (en) 2013-10-03
PL2646422T3 (pl) 2015-12-31
IL226053A (en) 2015-03-31
US8742103B2 (en) 2014-06-03
SMT201500230B (it) 2015-10-30
WO2012072663A9 (en) 2012-08-30
TWI428311B (zh) 2014-03-01
RS54397B1 (en) 2016-04-28
CA2816357A1 (en) 2012-06-07
EA022300B1 (ru) 2015-12-30
EA201300650A1 (ru) 2013-11-29
CN103228635B (zh) 2016-03-30
DK2646422T3 (en) 2015-10-05
KR101530924B1 (ko) 2015-06-23
JP5758010B2 (ja) 2015-08-05
MX2013006017A (es) 2013-07-15
MX345822B (es) 2017-02-17
BR112013010115A2 (pt) 2016-07-05
EP2646422B1 (en) 2015-07-08
PT2646422E (pt) 2015-10-20
ES2548038T3 (es) 2015-10-13
EP2646422A1 (en) 2013-10-09
SI2646422T1 (sl) 2016-02-29
CA2816357C (en) 2015-04-28
BR112013010115B1 (pt) 2018-12-04
WO2012072663A1 (en) 2012-06-07
CY1117407T1 (el) 2017-04-26
HUE026090T2 (en) 2016-05-30
CN103228635A (zh) 2013-07-31
JP2014504281A (ja) 2014-02-20

Similar Documents

Publication Publication Date Title
ZA201308086B (en) Derivatives of 1-anino-2-cyclopropylboronic acid
IL237581B (en) Derivatives of 6-oxo-pyrazinopyrrolopyrimidines
TWI561518B (en) Method of preparing an indole compound
HK1203192A1 (en) Method of preparation of enantiomers of spiro-oxindole compounds
PT2539136T (pt) Poste de barreira e método de fabrico do mesmo
SG11201405990PA (en) Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs
ZA201401013B (en) Novel imidazole amines as modulators of kinase activity
ZA201403513B (en) Bicyclic heterocyclic compound
ZA201207397B (en) Process for the preparation of dexlansoprazole
EP2578567A4 (en) PROCESS FOR THE PREPARATION OF IMIDE COMPOUNDS CONTAINING FLUORINE
IL226053A0 (en) Separation of enantiomers of triazine derivatives using tartaric acid
EP2680843A4 (en) DERIVATIVES OF PYRAZOLSUBSTITUTED AMINO-HETEROARYL COMPOUNDS
ZA201308884B (en) Production method of imidazole derivatives
EP2782902A4 (en) DERIVATIVES FROM PHENOXYISOBUTTERIC ACID
EP2791349A4 (en) SYNTHESIS OF N-ACETYL-D-NEURAMIC ACID
EP2578568A4 (en) PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED FLUOROPYRROLIDINE DERIVATIVES
GB2483682B (en) Method of securing fitted furniture
GB201008665D0 (en) Method of filtering
ZA201105238B (en) Levelling of supports